{"paper_id":"d4187bb0-19d9-4edd-9d7d-4e6b9dd8d121","body_text":"Peng-Hui Wang:  Conceptualization, Writing – original draft, Writing – review & editing.  Chun-An Chen:  Writing – original draft, Writing – review & editing.  Mayuko Sekiya:  Writing – original draft, Writing – review & editing.  Kiyohiko Nakai:  Writing – original draft, Writing – review & editing.  Junnosuke Matsushima:  Writing – original draft, Writing – review & editing.  Ayako Nishimoto-Kakiuchi:  Writing – original draft, Writing – review & editing.\n\nP.-H.W. reports funding from Chugai Pharmaceutical Co., Ltd., for the submitted work. C.-A.C. reports employee, stock options, travel support, and nonvoting support member of dose escalation committee for Chugai Pharmaceutical Co., Ltd. M.S. reports employee, stock options, travel support, and nonvoting support member of dose escalation committee for Chugai Pharmaceutical Co., Ltd. K.N. and J.M. are employees of Chugai Pharmaceuticals Co., Ltd. A.N.-K. reports travel support, inventor of the patents of anti-interleukin-8 antibodies and endometriosis (all rights have been assigned to Chugai), nonvoting support member of dose escalation committee, etc., stock and employee of Chugai Pharmaceutical Co., Ltd.","source_license":"public-domain-us","license_restricted":false}